D-0071-2023 Class II Ongoing

Recalled by Noven Pharmaceuticals Inc — Miami, FL

FDA drug recall D-0071-2023 was initiated by Noven Pharmaceuticals Inc on Nov 16, 2022 and is designated Class II. Reason for recall: Defective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal patches. The recall status is ongoing. Affected quantity: 3977 boxes.

Recall details

Product Type
Drugs
Report Date
Dec 7, 2022
Initiation Date
Nov 16, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3977 boxes

Product description

Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours, (1.6 mg/hr), 30 patches per box, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC 68968-5553-3.

Reason for recall

Defective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal patches.

Distribution pattern

Nationwide in the USA

Code information

Lot: 91316 Exp. 02/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0071-2023
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0071-2023. Report a data issue: hello@regdatalab.com.